Angela Heck1, Matthias Fastenrath2, David Coynel2, Bianca Auschra3, Horst Bickel4, Virginie Freytag3, Leo Gschwind2, Francina Hartmann3, Frank Jessen5, Hanna Kaduszkiewicz6, Wolfgang Maier7, Annette Milnik1, Michael Pentzek8, Steffi G Riedel-Heller9, Klara Spalek10, Christian Vogler1, Michael Wagner7, Siegfried Weyerer11, Steffen Wolfsgruber7, Dominique J-F de Quervain12, Andreas Papassotiropoulos13. 1. Division of Molecular Neuroscience, Department of Psychology, University of Basel, Basel, Switzerland2Psychiatric University Clinic, University of Basel, Basel, Switzerland. 2. Division of Molecular Neuroscience, Department of Psychology, University of Basel, Basel, Switzerland3Division of Cognitive Neuroscience, Department of Psychology, University of Basel, Basel, Switzerland. 3. Division of Molecular Neuroscience, Department of Psychology, University of Basel, Basel, Switzerland. 4. Department of Psychiatry, Technical University of Munich, Munich, Germany. 5. Department of Psychiatry, University of Cologne, Medical Faculty, Cologne, Germany6German Center for Neurodegenerative Diseases, Bonn, Germany. 6. Institute of General Practice, Kiel University, Kiel, Germany. 7. German Center for Neurodegenerative Diseases, Bonn, Germany8Department of Psychiatry, University of Bonn, Bonn, Germany. 8. Department of General Practice, University Medical Center Düsseldorf, Düsseldorf, Germany. 9. Institute of Social Medicine, Occupational Health, and Public Health, University of Leipzig, Leipzig, Germany. 10. Division of Cognitive Neuroscience, Department of Psychology, University of Basel, Basel, Switzerland. 11. Central Institute of Mental Health, Mannheim/Heidelberg University, Mannheim, Germany. 12. Psychiatric University Clinic, University of Basel, Basel, Switzerland3Division of Cognitive Neuroscience, Department of Psychology, University of Basel, Basel, Switzerland. 13. Division of Molecular Neuroscience, Department of Psychology, University of Basel, Basel, Switzerland2Psychiatric University Clinic, University of Basel, Basel, Switzerland12Life Sciences Training Facility, Department Biozentrum, University of Basel, Base.
Abstract
IMPORTANCE: Human episodic memory performance is linked to the function of specific brain regions, including the hippocampus; declines as a result of increasing age; and is markedly disturbed in Alzheimer disease (AD), an age-associated neurodegenerative disorder that primarily affects the hippocampus. Exploring the molecular underpinnings of human episodic memory is key to the understanding of hippocampus-dependent cognitive physiology and pathophysiology. OBJECTIVE: To determine whether biologically defined groups of genes are enriched in episodic memory performance across age, memory encoding-related brain activity, and AD. DESIGN, SETTING, AND PARTICIPANTS: In this multicenter collaborative study, which began in August 2008 and is ongoing, gene set enrichment analysis was done by using primary and meta-analysis data from 57 968 participants. The Swiss cohorts consisted of 3043 healthy young adults assessed for episodic memory performance. In a subgroup (n = 1119) of one of these cohorts, functional magnetic resonance imaging was used to identify gene set-dependent differences in brain activity related to episodic memory. The German Study on Aging, Cognition, and Dementia in Primary Care Patients cohort consisted of 763 elderly participants without dementia who were assessed for episodic memory performance. The International Genomics of Alzheimer's Project case-control sample consisted of 54 162 participants (17 008 patients with sporadic AD and 37 154 control participants). Analyses were conducted between January 2014 and June 2015. Gene set enrichment analysis in all samples was done using genome-wide single-nucleotide polymorphism data. MAIN OUTCOMES AND MEASURES: Episodic memory performance in the Swiss cohort and German Study on Aging, Cognition, and Dementia in Primary Care Patients cohort was quantified by picture and verbal delayed free recall tasks. In the functional magnetic resonance imaging experiment, activation of the hippocampus during encoding of pictures served as the phenotype of interest. In the International Genomics of Alzheimer's Project sample, diagnosis of sporadic AD served as the phenotype of interest. RESULTS: In the discovery sample, we detected significant enrichment for genes constituting the calcium signaling pathway, especially those related to the elevation of cytosolic calcium (P = 2 × 10-4). This enrichment was replicated in 2 additional samples of healthy young individuals (P = .02 and .04, respectively) and a sample of healthy elderly participants (P = .004). Hippocampal activation (P = 4 × 10-4) and the risk for sporadic AD (P = .01) were also significantly enriched for genes related to the elevation of cytosolic calcium. CONCLUSIONS AND RELEVANCE: By detecting consistent significant enrichment in independent cohorts of young and elderly participants, this study identified that calcium signaling plays a central role in hippocampus-dependent human memory processes in cognitive health and disease, contributing to the understanding and potential treatment of hippocampus-dependent cognitive pathology.
IMPORTANCE: Humanepisodic memory performance is linked to the function of specific brain regions, including the hippocampus; declines as a result of increasing age; and is markedly disturbed in Alzheimer disease (AD), an age-associated neurodegenerative disorder that primarily affects the hippocampus. Exploring the molecular underpinnings of humanepisodic memory is key to the understanding of hippocampus-dependent cognitive physiology and pathophysiology. OBJECTIVE: To determine whether biologically defined groups of genes are enriched in episodic memory performance across age, memory encoding-related brain activity, and AD. DESIGN, SETTING, AND PARTICIPANTS: In this multicenter collaborative study, which began in August 2008 and is ongoing, gene set enrichment analysis was done by using primary and meta-analysis data from 57 968 participants. The Swiss cohorts consisted of 3043 healthy young adults assessed for episodic memory performance. In a subgroup (n = 1119) of one of these cohorts, functional magnetic resonance imaging was used to identify gene set-dependent differences in brain activity related to episodic memory. The German Study on Aging, Cognition, and Dementia in Primary Care Patients cohort consisted of 763 elderly participants without dementia who were assessed for episodic memory performance. The International Genomics of Alzheimer's Project case-control sample consisted of 54 162 participants (17 008 patients with sporadic AD and 37 154 control participants). Analyses were conducted between January 2014 and June 2015. Gene set enrichment analysis in all samples was done using genome-wide single-nucleotide polymorphism data. MAIN OUTCOMES AND MEASURES: Episodic memory performance in the Swiss cohort and German Study on Aging, Cognition, and Dementia in Primary Care Patients cohort was quantified by picture and verbal delayed free recall tasks. In the functional magnetic resonance imaging experiment, activation of the hippocampus during encoding of pictures served as the phenotype of interest. In the International Genomics of Alzheimer's Project sample, diagnosis of sporadic AD served as the phenotype of interest. RESULTS: In the discovery sample, we detected significant enrichment for genes constituting the calcium signaling pathway, especially those related to the elevation of cytosolic calcium (P = 2 × 10-4). This enrichment was replicated in 2 additional samples of healthy young individuals (P = .02 and .04, respectively) and a sample of healthy elderly participants (P = .004). Hippocampal activation (P = 4 × 10-4) and the risk for sporadic AD (P = .01) were also significantly enriched for genes related to the elevation of cytosolic calcium. CONCLUSIONS AND RELEVANCE: By detecting consistent significant enrichment in independent cohorts of young and elderly participants, this study identified that calcium signaling plays a central role in hippocampus-dependent human memory processes in cognitive health and disease, contributing to the understanding and potential treatment of hippocampus-dependent cognitive pathology.
Authors: Evangelia Stergiakouli; Marian Hamshere; Peter Holmans; Kate Langley; Irina Zaharieva; Ziarah Hawi; Lindsey Kent; Michael Gill; Nigel Williams; Michael J Owen; Michael O'Donovan; Anita Thapar Journal: Am J Psychiatry Date: 2012-02 Impact factor: 18.112
Authors: Eduardo Pérez-Palma; Bernabé I Bustos; Camilo F Villamán; Marcelo A Alarcón; Miguel E Avila; Giorgia D Ugarte; Ariel E Reyes; Carlos Opazo; Giancarlo V De Ferrari Journal: PLoS One Date: 2014-04-22 Impact factor: 3.240
Authors: Vanja Vukojevic; David Coynel; Navid R Ghaffari; Virginie Freytag; Thomas Elbert; Iris-Tatjana Kolassa; Sarah Wilker; James L McGaugh; Andreas Papassotiropoulos; Dominique J-F de Quervain Journal: Proc Natl Acad Sci U S A Date: 2020-08-17 Impact factor: 11.205
Authors: A Cipriani; K Saunders; M-J Attenburrow; J Stefaniak; P Panchal; S Stockton; T A Lane; E M Tunbridge; J R Geddes; P J Harrison Journal: Mol Psychiatry Date: 2016-05-31 Impact factor: 15.992
Authors: Virginie Freytag; Tania Carrillo-Roa; Annette Milnik; Philipp G Sämann; Vanja Vukojevic; David Coynel; Philippe Demougin; Tobias Egli; Leo Gschwind; Frank Jessen; Eva Loos; Wolfgang Maier; Steffi G Riedel-Heller; Martin Scherer; Christian Vogler; Michael Wagner; Elisabeth B Binder; Dominique J-F de Quervain; Andreas Papassotiropoulos Journal: Nat Commun Date: 2017-04-26 Impact factor: 14.919
Authors: Paul J Harrison; Andrea Cipriani; Catherine J Harmer; Anna C Nobre; Kate Saunders; Guy M Goodwin; John R Geddes Journal: Ann N Y Acad Sci Date: 2016-02 Impact factor: 5.691
Authors: Darine Villela; Claudia K Suemoto; Carlos A Pasqualucci; Lea T Grinberg; Carla Rosenberg Journal: Front Genet Date: 2016-06-14 Impact factor: 4.599